PACTR201810902005232Other1 期
Effectiveness of Drotaverine HCL in reducing the duration of first stage of labour among nulliparous women at Federal Teaching Hospital, Abakaliki.
Ikeotuonye Arinze0 个研究点目标入组 220 人开始时间: 2018年9月4日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- Other
- 发起方
- 入组人数
- 220
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- Female
入选标准
- •Nullipara or primigravida
- •Cervical dilation of 4-5cm only
- •No prior use of spasmolytics
排除标准
- •Coexisting masses
- •Allergy to Drotaverine HCL
研究者
相似试验
招募中
Unknown
Efficacy of drotaverine hydrochloride in reducing duration of labour in term pregnancies at Nnamdi Azikiwe University Teaching Hospital, Nnewi: a double-blind randomised controlled studyPACTR202311852717227Obinna Carl Okafor128
已完成
4 期
Role of Drotaverine hydrochloride in children with recurrent abdominal paiCTRI/2012/07/002765Walter Bushnell Pvt Ltd130
已完成
3 期
Drotaverine Hydrochloride Versus Hyoscine-N-butylbromide for Duodenal Antimotility During Endoscopic Retrograde Cholangiopancreatography (ERCP)ERCPPancreatic DiseasesBile Duct DiseasesNCT00731198Changhai Hospital650
已完成
不适用
Management of pain due to Intra Uterine Copper Device (Copper T) insertion with Drotaverine and Mefenamic acidCTRI/2014/05/004580All India Institute of Medical Sciences36
已完成
4 期
The effect of activated vitamin D on reducing the progression from impaired glucose tolerance (IGT) to type 2 diabetes (Phase IV, multicenter, randomized, double blind, placebo controlled, and parallel group comparison)Impaired Glucose Tolerance (IGT)JPRN-UMIN000010758Kokura Medical Association Health Testing and Services Center1,250